Dr. Agarwal's Health Care Limited — PPTs, 04-08-2026: Investor Presentation

Dr. Agarwal's Health Care continues its strong run! Q1'FY27 revenue shot up 26.0% YoY to ₹614 Cr. Net profit surged 44.6% to ₹55 Cr, with EBITDA climbing 25.2% to ₹177 Cr (28.5% margin). Surgeries remain the core revenue driver.

Growth is fueled by aggressive expansion, adding a record 18 new facilities this quarter. They plan 60 more in FY27, leveraging their asset-light hub-and-spoke model. Emerging facilities offer huge growth potential. Clinical innovation like Pinhole Pupilloplasty boosts specialized services, with Femto Cataracts up 33.4% YoY.

The company served 882K+ patients (+25.1% YoY) and performed 91K+ surgeries (+15.5% YoY). Same Store Sales Growth (SSSG) was a robust 16.3% for mature facilities. The balance sheet remains strong, indicating a net cash position of ₹62 Cr. Management is focused on expanding their market-leading position in India's fast-growing eye care sector.